NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price Purchase Price NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price admin September 6, 2025 0 Financing at 40% premium to market price provides near-term bridge to anticipated milestones CAMBRIDGE, Mass., <span... Read More Read more about NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price
